Zinc supplementation in preterm neonates with jaundice:is it beneficial?

Zinc supplementation in preterm neonates with jaundice,is it beneficial?:A randomized controlled trial

Status

Active, not recruiting

Phases

Phase 1Phase 2

Study type

Interventional

Source

TCTR

Registry ID

TCTR20200504007

Enrollment

Unknown

Registered

2020-05-04

Start date

2016-06-30

Completion date

Unknown

Last updated

2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

neonatal jaundice neonate &#44

Interventions

zinc is a trace element that was given to the jaundiced neonate&#44

In the intervention group&#44

100 preterm neonates with jaundice received zinc as 0.6 cm of zinc origin/kg/day orally through oro/nasogastric tube divided into 2 doses(/12 hours) which is equal 1.2 mg elemental zinc/kg/day orally

phototherapy produce blue ultraviolet rays for 1decreasing jaundice for a duration of 10 days

Experimental Drug,Experimental Device

Zinc adminstration,phototherapy

Eligibility

Sex/Gender

All

Age

0 Days to 28 Days

Inclusion criteria

Inclusion criteria: preterm neonates

Exclusion criteria

Exclusion criteria: full term neonate

Design outcomes

Primary

Measure	Time frame
jaundice at 10 days after end of the intervention(zinc administration) ELISA method for measuring bilirubin in jaundiced neonate	—

Secondary

Measure	Time frame
Detailed and quantity of blood transfusion 12 months retrospective chart review,underlying maternal hematocrit 12 months retrospective chart review,underlying maternal disease 12 months retrospective chart review	—

Countries

Egypt

Contacts

Public Contactmohamed elfarargy

Tanta University Hospital

farargy2009@hotmail.com0020403343396

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Apr 4, 2026